Madrid: Spain has allowed the medication derived from cannabis - the main ingredient in marijuana - for the treatment of spasticity in patients with multiple sclerosis. Health Minister Trinidad Jimenez said the therapeutic use of cannabis has been studied for "many years" and is well-documented in clinical trials.
She said this is about "a very specific use, if other treatments have failed, if and when authorized by a (health) specialist and for a very reduced group of patients." "(It`s prescription) could be studied if the medical specialist considers it to be appropriate and when other kinds of medications have failed, but it would be on a case-by-case basis and for a very controlled group of (patients)," she said. Meanwhile, GW Pharmaceuticals has begun registration procedures for the approval of Sativex in European Union member countries, including the bloc`s main markets of Germany, France and Italy. IANS
Clean chit to Modi in Gujarat riots premature: Rahul
Communal forces have invaded UP: Lalu Yadav
Will AAP field Kejriwal from Varanasi?
AAP releases LS candidates` list, Shazia Ilmi gets Ghaziabad ticket